Numinus Wellness Inc. has filed all its quarterly financial reports for fiscal 2026, fulfilling regulatory requirements to potentially lift the British Columbia Securities Commission's cease trade order. The company reported stable revenue of $4.5 million for Q3 2026, with a gross profit of $0.9 million and a cash position of $0.5 million. Management is pursuing a listing on the Canadian Securities Exchange to restore trading and improve shareholder liquidity, contingent on meeting listing criteria. This move aims to support Numinus's growth in innovative mental health treatments using psychedelic-assisted therapies.
Between August 22 and August 30, combined leveraged positions on Binance and Bybit for Ethereum plummeted 90.9%, falling from $1.12 billion to $102 million. Despite this sharp decline in derivatives activity, Ethereum's price remained stable near $2,...
DeFi Development Corp. has proposed raising up to $20 million to increase its holdings of SOL, the native token of the Solana blockchain. This move extends the company's strategy of building a Solana-focused corporate treasury, following recent token...
XRP surged from about $1 to nearly $1.70 in August, marking its best monthly gain since 2021, driven largely by $153.55 million inflows into US spot XRP ETFs, mostly in the latter half of the month. Analyst Ali Martinez confirmed a breakout above res...
BWX Technologies is rated a buy, supported by its exclusive role as the sole manufacturer of nuclear reactors and fuel for the U.S. Navy and strong government contracts that make up 67% of its revenue. The company also benefits from accelerating comm...
Ethereum's price increased by 2.25% to $2,471.16, following a strong 32.8% gain in August. The price remains above key technical support at $2,247.57, signaling bullish momentum, while resistance sits near $2,783.71. A large whale moved over 102,000 ...
